PI
Prashant Indukumar Mehta
About Prashant Indukumar Mehta
Data last updated:
Prashant Indukumar Mehta has 1 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Novitious Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Novitious Pharmaceutical Private Limited at ₹4.97 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novitious Pharmaceutical Private Limited U51397GJ2022PTC134948 | Managing Director | 01 Mar 2025 | 2022 | ₹4.97 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Prashant Indukumar Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prashant Indukumar Mehta
Prashant Indukumar Mehta has 1 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Novitious Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Novitious Pharmaceutical Private Limited at ₹4.97 Cr (FY 2025).
Prashant Indukumar Mehta is associated with 1 company as Managing Director, including Novitious Pharmaceutical Private Limited (₹4.97 Cr).
Prashant Indukumar Mehta has expertise in General Business.
Prashant Indukumar Mehta has 1 years in corporate governance.
By reported revenue, the largest current company of Prashant Indukumar Mehta is Novitious Pharmaceutical Private Limited, with revenue of ₹4.97 Cr (FY 2025).
Prashant Indukumar Mehta currently holds positions at 1 company: Novitious Pharmaceutical Private Limited (₹4.97 Cr).